Access to CAR T-cell therapy is currently limited to certain clinical trials and approved treatment centers. Patients interested in this therapy should consult with their healthcare provider to determine if they are eligible candidates. Participation in clinical trials is also an option for patients who meet specific criteria and are willing to contribute to the advancement of cancer treatment.
